GPR17 Activators
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PF9 tetrasodium salt | 851265-78-6 | sc-362783 | 1 mg | $235.00 | ||
PF9 tetrasodium salt functions as a GPR17 modulator, exhibiting a unique affinity for the receptor's orthosteric binding site. This interaction triggers specific downstream signaling pathways, influencing cellular responses. Its ionic nature enhances solubility and facilitates rapid diffusion across membranes, promoting efficient receptor engagement. The compound's distinct charge distribution and steric configuration contribute to its selective binding kinetics, allowing for precise modulation of GPR17 activity. | ||||||
Uridine-5′-diphosphoglucose, disodium salt | 117756-22-6 | sc-296687 sc-296687A sc-296687B sc-296687C sc-296687D sc-296687E | 100 mg 1 g 10 g 50 g 100 g 1 kg | $99.00 $458.00 $2611.00 $13015.00 $16657.00 $41106.00 | 1 | |
Uridine-5'-diphosphoglucose, disodium salt acts as a GPR17 modulator, characterized by its ability to engage in specific hydrogen bonding interactions with receptor sites. This compound influences intracellular signaling cascades, impacting various metabolic pathways. Its dual phosphate groups enhance electrostatic interactions, promoting stability in aqueous environments. The compound's unique stereochemistry allows for tailored binding dynamics, facilitating nuanced regulatory effects on GPR17 activity. | ||||||
Uridine | 58-96-8 | sc-296685 sc-296685A | 1 g 25 g | $61.00 $100.00 | 1 | |
A nucleoside that can bind to GPR17, potentially modulating its activity by influencing purinergic signaling pathways. | ||||||
ONO 1078 | 103177-37-3 | sc-204148 | 50 mg | $66.00 | ||
Another leukotriene receptor antagonist, it can indirectly influence GPR17 activity through the modulation of leukotriene pathways. | ||||||
Zafirlukast | 107753-78-6 | sc-204942 sc-204942A | 10 mg 100 mg | $37.00 $174.00 | 1 | |
A leukotriene receptor antagonist, potentially affecting GPR17 by altering leukotriene signaling pathways. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
A purine nucleoside that can influence purinergic signaling pathways, potentially modulating GPR17 activity. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
A P2 receptor antagonist, can influence purinergic signaling, indirectly affecting GPR17 activity. | ||||||